Nuclear-localized SIRT6 is notably downregulated in glioma and acts as a tumor suppressor through various mechanisms, including inhibition of the JAK2/STAT3 and NOTCH3 signaling pathways. Here, SIRT6 is linked to central nervous system cancer.